Human papillomavirus vaccination: if the vaccine is important and available, why not use it?
- PMID: 40332252
- PMCID: PMC12051950
- DOI: 10.1590/1806-9282.20240865
Human papillomavirus vaccination: if the vaccine is important and available, why not use it?
Abstract
Background: Human papillomavirus (HPV) is the most common virus of the reproductive tract, is linked to cervical cancer, and can be prevented by vaccination, which is most effective if the vaccine is administered before sexual activity begins.
Methods: This descriptive, cross-sectional, and qualitative study was based on a survey containing 15 questions delivered to schools in three cities in the ABC region. Two schools from high-income neighborhoods and two from low-income neighborhoods were selected in each city based on real estate values. Data were expressed in absolute numbers and percentages and interpreted by descriptive analysis. The statistical tests of association were performed.
Results: Twelve schools were invited and nine agreed to participate. Of the 4,503 questionnaires delivered, 1,921 were completed by parents and guardians. The vaccination rate was 56.05% in private schools and 66.58% in public schools. Private vs. public school was not an independent factor for vaccination, but residing in a low-income neighborhood and city was a determinant factor. Approximately 40% of the parents/guardians reported not having their children vaccinated, primarily due to concerns about adverse effects.
Conclusion: Despite being freely available and proven effective, the human papillomavirus vaccine remains underutilized. The reasons exposed in this paper may be useful in strategies to enhance vaccination coverage.
Trial registration: This study was approved by the research ethics committee under the number 2.143.196.
Conflict of interest statement
Similar articles
-
Factors related to non-compliance to HPV vaccination in Roraima-Brazil: a region with a high incidence of cervical cancer.BMC Health Serv Res. 2016 Aug 22;16(1):417. doi: 10.1186/s12913-016-1677-y. BMC Health Serv Res. 2016. PMID: 27550325 Free PMC article.
-
Knowledge and willingness of parents towards child girl HPV vaccination in Debre Tabor Town, Ethiopia: a community-based cross-sectional study.Reprod Health. 2022 Jun 10;19(1):136. doi: 10.1186/s12978-022-01444-4. Reprod Health. 2022. PMID: 35689288 Free PMC article.
-
Uptake of Human Papilloma Virus Vaccination and Associated Factors Among Female Students Attending Secondary Schools in South West Shoa, Oromia, Ethiopia, 2022.Cancer Control. 2024 Jan-Dec;31:10732748241285271. doi: 10.1177/10732748241285271. Cancer Control. 2024. PMID: 39288978 Free PMC article.
-
Parents' Intentions of Human Papillomavirus Vaccination for Students in Vietnam: A Cross-Sectional Study.Cancer Control. 2024 Jan-Dec;31:10732748241284907. doi: 10.1177/10732748241284907. Cancer Control. 2024. PMID: 39270069 Free PMC article.
-
Parental knowledge gaps and barriers for children receiving human papillomavirus vaccine in the Rio Grande Valley of Texas.Hum Vaccin Immunother. 2019;15(7-8):1678-1687. doi: 10.1080/21645515.2019.1628551. Epub 2019 Jun 26. Hum Vaccin Immunother. 2019. PMID: 31170031 Free PMC article.
References
-
- Gearhart PA. Human papillomavirus. [[cited on 2024 Jun 13]]. 2024. Available from: http://emedicine.medscape.com/article/219110-overview#a2 .
-
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi: 10.3322/caac.21492. . Erratum in: CA Cancer J Clin. 2020;70(4):313. - DOI - PubMed
-
- International Agency for Research on Cancer (IARC) [[cited on 2024 June 13]]. 2024. Available from: https://gco.iarc.fr/today/home .